Opendata, web and dolomites

ProteinPlus SIGNED

Let's give the world appetite for health

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ProteinPlus project word cloud

Explore the words cloud of the ProteinPlus project. It provides you a very rough idea of what is the project "ProteinPlus" about.

treatment    designed    120    dramatically    manufacturers    compliance    food    smart    half    million    abbott    technological    emulsar    75m    tons    nanotechnology    meet    hyperproteinic    healthcare    industrial    public    reducing    supplements    commercial    prepare    induce    nestl    optimize    proved    copy    competitiveness    revenues    illness    disease    launch    validate    manufacture    specially    health    mass    full    employees    create    limiting    sent    founded    lab    fresenius    10bn    oral    barrier    burden    170bn    malnutrition    reduce    leader    dominated    patented    bad    market    sizes    volume    nice    generating    levels    capital    invented    tastier    emulsion    plus    standards    volumes    hundreds    clinical    proteins    europeans    ingredients    healthier    deficiencies    disruptive    gap    dense    medical    sustainability    ingredient    reaching    patients    2020    2004    unilever    nutricia    transition    50    proof    savings    eacute    compatibility    casino    effectiveness    proving    2012    taste    33    ons    overcomes    nutrition    prevents    protein    nutritional    foods    formulated    portion    density   

Project "ProteinPlus" data sheet

The following table provides information about the project.

Coordinator
EMULSAR 

Organization address
address: 26-28 rue Marius Aufan
city: Levallois-Perret
postcode: 92300
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Project website http://www.emulsar.com/
 Total cost 2˙449˙800 €
 EC max contribution 1˙714˙860 € (70%)
 Programme 1. H2020-EU.2.1.5. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing)
2. H2020-EU.2.1.3. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-2-2016-2017
 Funding Scheme SME-2
 Starting year 2016
 Duration (year-month-day) from 2016-09-01   to  2020-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    EMULSAR FR (Levallois-Perret) coordinator 1˙714˙860.00

Map

 Project objective

Disease-related malnutrition affects 33 million Europeans, a burden of 170bn€ for the EU. Oral Nutritional Supplements (ONS) are specially formulated foods designed to meet patients’ nutritional deficiencies during illness. This $10Bn ONS market is dominated by Nutricia, Nestlé, Fresenius & Abbott.

However, large portion sizes and bad taste in ONS induce very low levels of treatment compliance (50%), dramatically limiting effectiveness. Manufacturers face a technological barrier that prevents them from increasing protein density and thus reducing volume.

The aim of the project is to bring to the market a disruptive hyperproteinic ingredient – Protein Plus© - for ONS manufacturers, that overcomes this technology gap.

Founded in 2004, EMULSAR invented and patented its Smart Emulsion Nanotechnology© (SENT©), used to manufacture disruptive ingredients for health and nutrition. Since 2012, SENT© has produced hundreds of tons of food ingredients (used by Casino, Unilever…to create healthier & tastier products), proving its industrial sustainability and compatibility with commercial food standards.

In Phase 1, we proved (at lab-scale) that by applying SENT© to proteins, we can produce a protein-dense ingredient that makes it possible to reduce current ONS volumes by half.

Our Phase 2 objectives are to optimize our Protein Plus© ingredient, validate the industrial process, establish clinical proof of improved ONS compliance & prepare our market launch.

Our project will improve the competitiveness of ONS products, create public healthcare savings and enhance Europe’s health capital. For EMULSAR, the ONS market is the best path for becoming a European technology leader in health food, allowing EMULSAR to transition from nice-to-have applications (mass-market food) to must-have applications (medical nutrition). The current project is the key to reaching the full commercial potential of our nanotechnology, generating 75M€ in revenues & managing 120 employees by 2020.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PROTEINPLUS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PROTEINPLUS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.5.;H2020-EU.2.1.3.;H2020-EU.2.3.1.;H2020-EU.2.1.2.)

SUPPLEPRINT (2018)

Super Productive Line Printing Inkjet

Read More  

Volumizer (2018)

A natural, non-surgical, and safe facial filler which treats the root cause of facial ageing.

Read More  

STAR (2018)

Safe, Transparent, Active and Reliable mineral sunscreen technology

Read More